Brazilian multicenter study on efficacy and tolerability of trandolapril in mild-to-moderate essential arterial hypertension. Embathe substudy with ambulatory blood pressure monitoring

Arquivos Brasileiros de Cardiologia

Volumn 72, Issue 5, 1999, Pages 553-557

  Kohlmann Jr , Osvaldo ^a   Veiga Jardim, Paulo César B ^b   Oigman, Wille ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Ace inhibitor; Mild to moderate hypertension; Trandolapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANDOLAPRIL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAZIL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INDOLES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032871959     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. N'Guyen Cong Duc L. Brunner HR. Trandolapril in hypertension overview of a new angiotensin-converting enzyme inhibitor. Am J Cardiol 1992; 70(suppl): 27-34.
2. De Bruijin JHB. Orofiamma BA, Pauly NC. Efficacy and tolerance of trandolapril (0.5 to 2.0 mg) administered for 4 weeks in patients with mild-to-moderate hypertension. J Cardiovasc Pharmacol (no prelo).
3. De Bruijin JHB, Pauly NC. Placebo controlled dose-ranging study of the efficacy ans safety of 0.5, 1 and 2 mg trandolapil in patients with mild to moderate hypertension - a double-blind multicentre international trial (abstract). J Hypertens 1992; 10(suppl 4): 198.
4. Pauly NC, Safar ME. Placebo-controlled comparison of short-term efficacy and safety of 2, 4 and 8 mg trandolapril in patients with mild to moderate hyper-tension-double-blind international multiccntie trial. J Hypertens 1992; 10(suppl.4): 299.
5. Wiseman LR, McTavish D. Trandolapril: A Review, Drugs 1994; 48: 83.
6. Poirer L, Bougeois J. Lacourcière Y. Once-daily trnadolapril compared with twice-daily for nulation in the treatment of mild to moderate hypertension: assessment by conventional and ambulatory blood pressures. J Clin Pharmacol 1993; 33: 832-6.
7. Hidaka H, Watanabe T, Kurokawa K. Effect of RU44570 (trandolapril) on the blood pressure and serum lipids in patients with essential hypertension [in Japanese]. Rinsno Iyaku 1992; 8(suppl 7): 191-204.